These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10147118)

  • 41. [Anti-endotoxin monoclonal antibodies in the treatment of gram-negative germ sepsis].
    Baumgartner JD
    Rev Prat; 1991 Jun; 41(16):1479-82. PubMed ID: 1853112
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal antibodies for gram-negative sepsis.
    Med Lett Drugs Ther; 1991 Nov; 33(856):103-4. PubMed ID: 1943976
    [No Abstract]   [Full Text] [Related]  

  • 44. Monoclonal antibodies to endotoxin. New allies against sepsis?
    Bone RC
    JAMA; 1991 Aug; 266(8):1125-6. PubMed ID: 1865548
    [No Abstract]   [Full Text] [Related]  

  • 45. Empiric antimicrobial therapy for Gram-negative sepsis: back to the future.
    Leekha S; Standiford HC
    Crit Care Med; 2011 Aug; 39(8):1995-6. PubMed ID: 21768802
    [No Abstract]   [Full Text] [Related]  

  • 46. Novel monoclonal antiendotoxin antibody therapy: efficacy at any price?
    Fant WK
    Pharmacoeconomics; 1993 Jun; 3(6):437-45. PubMed ID: 10146878
    [No Abstract]   [Full Text] [Related]  

  • 47. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group.
    Greenman RL; Schein RM; Martin MA; Wenzel RP; MacIntyre NR; Emmanuel G; Chmel H; Kohler RB; McCarthy M; Plouffe J
    JAMA; 1991 Aug; 266(8):1097-102. PubMed ID: 1865542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
    van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630
    [No Abstract]   [Full Text] [Related]  

  • 49. Human monoclonal antibodies in sepsis.
    Smith C; Straube R; Wortel C
    Neth J Med; 1991 Oct; 39(3-4):177-9. PubMed ID: 1824049
    [No Abstract]   [Full Text] [Related]  

  • 50. Polyclonal bacteremia due to gram-negative rods.
    Wendt C; Grunwald WJ
    Clin Infect Dis; 2001 Aug; 33(4):460-5. PubMed ID: 11462180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Centoxin.
    Davidson J; Tarlow M
    Br J Hosp Med; 1993 Jan 20-Feb 2; 49(2):121-2. PubMed ID: 8435673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human monoclonal antibodies in sepsis.
    de Koning J; Westendorp RG
    Neth J Med; 1992 Apr; 40(3-4):215. PubMed ID: 1603215
    [No Abstract]   [Full Text] [Related]  

  • 53. Generation of a protective human monoclonal for the treatment of gram-negative sepsis.
    Larrick JW; Gray O; Deinhart T; Wang J; Flatgaard J; Chong KT
    Prog Clin Biol Res; 1988; 272():383-93. PubMed ID: 3393571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Centoxin: the full story of its withdrawal.
    Andrews PA
    Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490693
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Centoxin: the full story of its withdrawal.
    Choyce MQ
    Br J Hosp Med; 1993 Apr 7-20; 49(7):517. PubMed ID: 8490694
    [No Abstract]   [Full Text] [Related]  

  • 57. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.
    Johnson MT; Reichley R; Hoppe-Bauer J; Dunne WM; Micek S; Kollef M
    Crit Care Med; 2011 Aug; 39(8):1859-65. PubMed ID: 21499086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiendotoxin monoclonal antibodies. What future now?
    Susla GM; Dew RB
    Drug Saf; 1994 Oct; 11(4):215-22. PubMed ID: 7848542
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe sepsis and septic shock: the role of gram-negative bacteremia.
    Munford RS
    Annu Rev Pathol; 2006; 1():467-96. PubMed ID: 18039123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia.
    Pogue JM; Mynatt RP; Marchaim D; Zhao JJ; Barr VO; Moshos J; Sunkara B; Chopra T; Chidurala S; Kaye KS
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):132-8. PubMed ID: 24442074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.